Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi

Tropical Medicine and International Health

Volumn 14, Issue 8, 2009, Pages 862-869

  Fetzer, Bradley C ^a   Hosseinipour, Mina C ^b,g   Kamthuzi, Portia ^b   Hyde, Lisa ^b   Bramson, Brian ^c   Jobarteh, Kebba ^d   Torjesen, Kristine ^a   Miller, William C ^a   Hoffman, Irving ^a   Kazembe, Peter ^e   Mwansambo, Charles ^f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^c Wake County Health Department   (United States)

^d PARTNERS IN HEALTH   (United States)

^e Baylor Children's Foundation Malawi   (Malawi)

^f KAMUZU CENTRAL HOSPITAL   (Malawi)

^g CB#7030 ^*  (United States)

Author keywords

Anti retroviral therapy; HIV AIDS; Malawi; Mortality; Paediatrics

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

CHILD HEALTH; COHORT ANALYSIS; DISEASE TREATMENT; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY RISK; MULTIVARIATE ANALYSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; PREDICTOR VARIABLE; PRESCHOOL CHILD; SCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PATIENT DROPOUTS; TREATMENT OUTCOME;

AFRICA; EAST AFRICA; LILONGWE; MALAWI; SUB-SAHARAN AFRICA;

EID: 68949105542     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02315.x     Document Type: Article

References (37)

1. Barlow WE, Ichikawa L, Rosner D Izumi S (1999) Analysis of case-cohort designs. Journal of Clinical Epidemiology 52, 1165 1172.
2. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Journal of the American Medical Association 298, 1888 1899.
3. Bong CN, Yu JK, Chiang HC et al. (2007) Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS 21, 1805 1810.
4. Boyd MA Cooper DA (2007) Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research. AIDS 21, S55 S63.
5. Brahmbhatt H, Kigozi G, Wabwire-Mangen F et al. (2006) Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. Journal of Acquired Immune Deficiency Syndromes 41, 504 508.
6. Cachafeiro A, Sherman G, Sohn A, Beck-Sague C Fiscus S (2008) Dried blood spots and the ultra-sensitive p24 antigen assay for the diagnosis of perinatal HIV infection. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA, USA. 3-6 Feburary 2008, Abstract 928.
7. Callens SF, Shabani N, Lusiama J et al. (2009) Mortality and associated factors after initiation of pediatric antiretroviral treatment in the democratic Republic of the Congo. Pediatric Infectious Disease Journal 28, 35 40.
8. Chearskul S, Chotpitayasunondh T, Simonds RJ et al. (2002) Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics 8, 1 6. Available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=12165624 (accessed on 15 June 2009).
9. Chilongozi D, Wang L, Brown L et al. (2008) Morbidity and mortality among a cohort of HIV-1-infected and uninfected pregnant women and their infants from Malawi, Zambia and Tanzania. Pediatric Infectious Disease Journal 27, 808 814.
10. Egger M, May M, Chene G et al. (2002) Prognosis of HIV-1 infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360, 119 129.
11. Eley B, Tindywebwa J, Kayita M et al. (2006) Contextualizing the paediatric HIV epidemic: a review. East African Medical Journal 83, 684 688.
12. Etard JF, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20, 1181 1189.
13. HIV Paediatric Prognostic Markers Collaborative Study (2005) Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data. Lancet 366, 1868 1874.
14. Hosseinipour MC, Neuhann F, Kanyama C, Namarika DC Phiri S (2004) Mortality is the Leading Cause of Loss to Follow-up Among Antiretroviral Patients in Malawi. 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, USA. 8-11 February 2004, Abstract 594.
15. Judd A, Doerholt K, Tookey PA et al. (2007) Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clinical Infectious Disease 45, 918 924.
16. Kiboneka A, Wangisi J, Nabiryo C et al. (2008) Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS 22, 2493 2499.
17. Libamba E, Makombe SD, Harries AD et al. (2007) Malawi's contribution to "3 by 5": achievements and challenges. Bulletin of the World Health Organization 85, 156 160.
18. Little K, Thorne C, Luo C et al. (2007) Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Current HIV Research 5, 139 153.
19. Lowrance D, Filler S, Makombe S et al. (2007) Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Tropical Medicine and International Health 12, 377 381.
20. Makombe S, Libamba E, Mhango E et al. (2006) Who is accessing antiretroviral therapy during national scale-up in Malawi? Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 975 979.
21. Malawi Paediatric Antiretroviral Treatment Group (2007) Antiretroviral therapy for children in the routine setting in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 101, 511 516.
22. Marinda E, Humphrey JH, Iliff PJ et al. (2007) Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatric Infectious Disease Journal 26, 519 526.
23. Mocroft A, Vella S, Benfield TL et al. (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352, 1725 1730.
24. MoH Malawi (2006) Malawi AntiRetroviral Therapy Guidelines, 2nd edn. Ministry of Health, Lilongwe.
25. MoH Malawi (2007) Quarterly report antiretroviral treatment programme in malawi with results up to 31st december, 2007, Ministry of Health, Lilongwe.
26. Ntozi JP, Lubaale YM Nakanaabi IM (1997) AIDS mortality in Uganda: circumstances, factors and impact of death. Health Transition Review 7, S207 S224.
27. Nyandiko WM, Ayaya S, Nabakwe E et al. (2006) Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. Journal of Acquired Immune Deficiency Syndromes 143, 418 425.
28. Resino S, Resino R, Maria Bellón J et al. (2006) Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clinical Infectious Diseases 43, 243 252.
29. Rothman KJ Greenland S (1998) Modern Epidemiology, 3rd Edn. Lippincott, New York.
30. UNAIDS (2006) Report on the Global AIDS Epidemic Annex 2. http://data.unaids.org/pub/GlobalReport/2006/2006-GR-ANN2-en.pdf (accessed on 29 December 2007).
31. United States Central Intelligence Agency (2007) World Factbook, Malawi Peoples. https://www.cia.gov/library/publications/the-world-factbook/geos/mi. html (accessed on 26 October 2007).
32. Violari A, Cottom MF, Gibb DM et al. (2008) Early antiretroviral therapy and mortality among HIV-infected infants. The New England Journal of Medicine 359, 2233 2244.
33. Walker AS, Mulenga V, Ford D et al. (2007) The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Journal of Clinical Infectious Diseases 44, 1361 1367.
34. WHO (2004) ART for Infection in Adults and Adolescents in Resource Limited Settings Towards Universal Access: Recommendations for a Public Health Approach. WHO, Geneva.
35. Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bulletin of the World Health Organization 85, 550 554.
36. Zachariah R, Fitzgerald M, Massaquoi M et al. (2006) Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 20, 2355 2360.
37. Zijlstra EE van Oosterhout JJ (2006) The introduction of antiretroviral therapy in Malawi. ed Tijdschr Geneeskd 150, 2774 2778.